Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis

Misa Suzuki, Kousuke Noda, Shunsuke Kubota, Manabu Hirasawa, Yoko Ozawa, Kazuo Tsubota, Nobuhisa Mizuki, Susumu Ishida

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: To investigate the effect of eicosapentaenoic acid (EPA) on acute ocular inflammation in an animal model of endotoxin-induced uveitis (EIU). Methods: C57Bl/6 mice (6-week-old males) were orally treated with EPA at a dose of 50 mg/kg/day for 5 days. EIU was then induced in the animals by intraperitoneal injection of 160 μg lipopolysaccharide (LPS). Twenty-four hours after LPS injection, leukocyte adhesion to the retinal vasculature was evaluated by the concanavalin A lectin perfusion-labeling technique, and leukocyte infiltration into the vitreous cavity was quantified. Furthermore, the protein levels of monocyte chemotactic protein (MCP)-1, interleukin (IL)-6, intercellular adhesion molecule-1 and phospholyrated nuclear factor (NF)-κB p65 in the retina and retinal pigment epithelium (RPE)-choroid complex were examined by enzyme-linked immunosorbent assay (ELISA). Results: At 24 h after LPS injection, the EIU animals treated with oral EPA administration showed a significant decrease in leukocyte adhesion to the retinal vessels by 43.4% (p<0.01) and leukocyte infiltration into the vitreous cavity by 49.2% (p<0.05). In addition, EPA significantly reduced the protein levels of MCP-1 and IL-6 in the retina and the RPE-choroid complex. Furthermore, phosphorylation of NF-κB was suppressed by EPA treatment. Conclusions: Our data suggest that EPA inhibits multiple inflammatory molecules in vivo. EPA may become a novel strategy in the prevention and/or treatment of ocular inflammatory diseases.

Original languageEnglish
Pages (from-to)1382-1388
Number of pages7
JournalMolecular Vision
Volume16
Publication statusPublished - 2010

Fingerprint

Eicosapentaenoic Acid
Uveitis
Endotoxins
Inflammation
Leukocytes
Lipopolysaccharides
Choroid
Retinal Pigment Epithelium
Chemokine CCL2
Retina
Interleukin-6
Retinal Vessels
Injections
Eye Diseases
Intercellular Adhesion Molecule-1
Concanavalin A
Intraperitoneal Injections
Lectins
Proteins
Animal Models

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Suzuki, M., Noda, K., Kubota, S., Hirasawa, M., Ozawa, Y., Tsubota, K., ... Ishida, S. (2010). Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. Molecular Vision, 16, 1382-1388.

Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. / Suzuki, Misa; Noda, Kousuke; Kubota, Shunsuke; Hirasawa, Manabu; Ozawa, Yoko; Tsubota, Kazuo; Mizuki, Nobuhisa; Ishida, Susumu.

In: Molecular Vision, Vol. 16, 2010, p. 1382-1388.

Research output: Contribution to journalArticle

Suzuki, M, Noda, K, Kubota, S, Hirasawa, M, Ozawa, Y, Tsubota, K, Mizuki, N & Ishida, S 2010, 'Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis', Molecular Vision, vol. 16, pp. 1382-1388.
Suzuki, Misa ; Noda, Kousuke ; Kubota, Shunsuke ; Hirasawa, Manabu ; Ozawa, Yoko ; Tsubota, Kazuo ; Mizuki, Nobuhisa ; Ishida, Susumu. / Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. In: Molecular Vision. 2010 ; Vol. 16. pp. 1382-1388.
@article{ebc2d12c8b074e8cbb544a5c2c1cdac0,
title = "Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis",
abstract = "Purpose: To investigate the effect of eicosapentaenoic acid (EPA) on acute ocular inflammation in an animal model of endotoxin-induced uveitis (EIU). Methods: C57Bl/6 mice (6-week-old males) were orally treated with EPA at a dose of 50 mg/kg/day for 5 days. EIU was then induced in the animals by intraperitoneal injection of 160 μg lipopolysaccharide (LPS). Twenty-four hours after LPS injection, leukocyte adhesion to the retinal vasculature was evaluated by the concanavalin A lectin perfusion-labeling technique, and leukocyte infiltration into the vitreous cavity was quantified. Furthermore, the protein levels of monocyte chemotactic protein (MCP)-1, interleukin (IL)-6, intercellular adhesion molecule-1 and phospholyrated nuclear factor (NF)-κB p65 in the retina and retinal pigment epithelium (RPE)-choroid complex were examined by enzyme-linked immunosorbent assay (ELISA). Results: At 24 h after LPS injection, the EIU animals treated with oral EPA administration showed a significant decrease in leukocyte adhesion to the retinal vessels by 43.4{\%} (p<0.01) and leukocyte infiltration into the vitreous cavity by 49.2{\%} (p<0.05). In addition, EPA significantly reduced the protein levels of MCP-1 and IL-6 in the retina and the RPE-choroid complex. Furthermore, phosphorylation of NF-κB was suppressed by EPA treatment. Conclusions: Our data suggest that EPA inhibits multiple inflammatory molecules in vivo. EPA may become a novel strategy in the prevention and/or treatment of ocular inflammatory diseases.",
author = "Misa Suzuki and Kousuke Noda and Shunsuke Kubota and Manabu Hirasawa and Yoko Ozawa and Kazuo Tsubota and Nobuhisa Mizuki and Susumu Ishida",
year = "2010",
language = "English",
volume = "16",
pages = "1382--1388",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis

AU - Suzuki, Misa

AU - Noda, Kousuke

AU - Kubota, Shunsuke

AU - Hirasawa, Manabu

AU - Ozawa, Yoko

AU - Tsubota, Kazuo

AU - Mizuki, Nobuhisa

AU - Ishida, Susumu

PY - 2010

Y1 - 2010

N2 - Purpose: To investigate the effect of eicosapentaenoic acid (EPA) on acute ocular inflammation in an animal model of endotoxin-induced uveitis (EIU). Methods: C57Bl/6 mice (6-week-old males) were orally treated with EPA at a dose of 50 mg/kg/day for 5 days. EIU was then induced in the animals by intraperitoneal injection of 160 μg lipopolysaccharide (LPS). Twenty-four hours after LPS injection, leukocyte adhesion to the retinal vasculature was evaluated by the concanavalin A lectin perfusion-labeling technique, and leukocyte infiltration into the vitreous cavity was quantified. Furthermore, the protein levels of monocyte chemotactic protein (MCP)-1, interleukin (IL)-6, intercellular adhesion molecule-1 and phospholyrated nuclear factor (NF)-κB p65 in the retina and retinal pigment epithelium (RPE)-choroid complex were examined by enzyme-linked immunosorbent assay (ELISA). Results: At 24 h after LPS injection, the EIU animals treated with oral EPA administration showed a significant decrease in leukocyte adhesion to the retinal vessels by 43.4% (p<0.01) and leukocyte infiltration into the vitreous cavity by 49.2% (p<0.05). In addition, EPA significantly reduced the protein levels of MCP-1 and IL-6 in the retina and the RPE-choroid complex. Furthermore, phosphorylation of NF-κB was suppressed by EPA treatment. Conclusions: Our data suggest that EPA inhibits multiple inflammatory molecules in vivo. EPA may become a novel strategy in the prevention and/or treatment of ocular inflammatory diseases.

AB - Purpose: To investigate the effect of eicosapentaenoic acid (EPA) on acute ocular inflammation in an animal model of endotoxin-induced uveitis (EIU). Methods: C57Bl/6 mice (6-week-old males) were orally treated with EPA at a dose of 50 mg/kg/day for 5 days. EIU was then induced in the animals by intraperitoneal injection of 160 μg lipopolysaccharide (LPS). Twenty-four hours after LPS injection, leukocyte adhesion to the retinal vasculature was evaluated by the concanavalin A lectin perfusion-labeling technique, and leukocyte infiltration into the vitreous cavity was quantified. Furthermore, the protein levels of monocyte chemotactic protein (MCP)-1, interleukin (IL)-6, intercellular adhesion molecule-1 and phospholyrated nuclear factor (NF)-κB p65 in the retina and retinal pigment epithelium (RPE)-choroid complex were examined by enzyme-linked immunosorbent assay (ELISA). Results: At 24 h after LPS injection, the EIU animals treated with oral EPA administration showed a significant decrease in leukocyte adhesion to the retinal vessels by 43.4% (p<0.01) and leukocyte infiltration into the vitreous cavity by 49.2% (p<0.05). In addition, EPA significantly reduced the protein levels of MCP-1 and IL-6 in the retina and the RPE-choroid complex. Furthermore, phosphorylation of NF-κB was suppressed by EPA treatment. Conclusions: Our data suggest that EPA inhibits multiple inflammatory molecules in vivo. EPA may become a novel strategy in the prevention and/or treatment of ocular inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=77955703750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955703750&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 1382

EP - 1388

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -